首页 > 最新文献

Clinical complementary medicine and pharmacology最新文献

英文 中文
HEMATOLOGY: general questions 血液学:一般问题
Pub Date : 2023-02-01 DOI: 10.12737/2409-3750-2023-8-4-2-13
E. Belyaeva
General issues of hematology, hematological syndromes, functions of blood cells, changes in general clinical blood analysis are considered.
一般问题的血液学,血液学综合征,血细胞的功能,在一般临床血液分析的变化被认为。
{"title":"HEMATOLOGY: general questions","authors":"E. Belyaeva","doi":"10.12737/2409-3750-2023-8-4-2-13","DOIUrl":"https://doi.org/10.12737/2409-3750-2023-8-4-2-13","url":null,"abstract":"General issues of hematology, hematological syndromes, functions of blood cells, changes in general clinical blood analysis are considered.","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"92 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80927860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RED FLY AGARIC IN MODERN MEDICINE (short message) 现代医学中的木耳红蝇(短信息)
Pub Date : 2023-02-01 DOI: 10.12737/2409-3750-2023-8-4-41-44
M. Gorelikov
Preparations of red fly agaric have anti-anxiety, antidepressant, psychostimulating, analgesic effect. The aim of the study is to identify the antidepressant, psychostimulating activity of the red fly agaric in order to select a priority direction for further in–depth research. Material and method of research. A preclinical preliminary study of the results of taking powder from the caps of the mushroom fly agaric red by volunteers – subscribers of the telegram channel t.me/zhaxar555 , with subsequent statistical processing of the feedback result. The research method was a questionnaire, the questionnaire consisted of a Beck depression scale, a sleep disturbance scale, and an emotional state questionnaire. Results and their discussion. The drug of mushroom origin significantly increased the level of the emotional and personal sphere, improved sleep, increased physical activity, the level of the motivational sphere, reduced the level of depressed and anxious mood. Conclusion. The questionnaire revealed a good efficacy of taking the body of the mushroom mu-homor red in monotherapy of mild subdepressive disorder, which determines the prospect of studying the drug in a further clinical study.
红蝇木耳制剂具有抗焦虑、抗抑郁、精神刺激、镇痛作用。本研究旨在鉴定红蝇木耳的抗抑郁、精神刺激活性,为进一步深入研究选择优先方向。研究的材料和方法。对电报频道t.me/zhaxar555的订户志愿者从蘑菇飞木耳红的帽子上取粉的结果进行临床前初步研究,并对反馈结果进行后续统计处理。研究方法采用问卷调查法,问卷由贝克抑郁量表、睡眠障碍量表和情绪状态问卷组成。结果和讨论。蘑菇源药物显著提高了情绪和个人领域水平,改善了睡眠,增加了身体活动,动机领域水平,降低了抑郁和焦虑情绪水平。结论。问卷调查结果显示,蘑菇红体单药治疗轻度亚抑郁障碍的疗效良好,这决定了该药物在进一步临床研究中的前景。
{"title":"RED FLY AGARIC IN MODERN MEDICINE (short message)","authors":"M. Gorelikov","doi":"10.12737/2409-3750-2023-8-4-41-44","DOIUrl":"https://doi.org/10.12737/2409-3750-2023-8-4-41-44","url":null,"abstract":"Preparations of red fly agaric have anti-anxiety, antidepressant, psychostimulating, analgesic effect. The aim of the study is to identify the antidepressant, psychostimulating activity of the red fly agaric in order to select a priority direction for further in–depth research. Material and method of research. A preclinical preliminary study of the results of taking powder from the caps of the mushroom fly agaric red by volunteers – subscribers of the telegram channel t.me/zhaxar555 , with subsequent statistical processing of the feedback result. The research method was a questionnaire, the questionnaire consisted of a Beck depression scale, a sleep disturbance scale, and an emotional state questionnaire. Results and their discussion. The drug of mushroom origin significantly increased the level of the emotional and personal sphere, improved sleep, increased physical activity, the level of the motivational sphere, reduced the level of depressed and anxious mood. Conclusion. The questionnaire revealed a good efficacy of taking the body of the mushroom mu-homor red in monotherapy of mild subdepressive disorder, which determines the prospect of studying the drug in a further clinical study.","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"129 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82857519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of mycophenolate mofetil in interstitial lung diseases associated with rheumatic diseases 霉酚酸酯在风湿病相关肺间质性疾病中的应用
Pub Date : 2023-02-01 DOI: 10.12737/2409-3750-2023-8-4-13-19
E. Ionova
Mycophenolate mofetil is an antimetabolite with a powerful inhibitory effect on the proliferation of T and B lymphocytes, the drug has been used since the early 1990s to prevent acute graft rejection after organ transplantation. It is also widely used for the treatment of various rheumatic diseases with lung damage. Interstitial lung disease is a heterogeneous group of progressive fibrotic lung diseases, which is often secondary to rheumatic disease and is a common cause of death. Mycophenolate mofetil is the main alternative to cyclophosphamide as a first-line drug for the treatment of interstitial lung diseases associated with rheumatic diseases, or as a possible maintenance therapy after treatment with cyclophosphamide with a lower frequency of side effects. However, the use of mycophenolate mofetil in interstitial lung diseases associated with rheumatic diseases has insufficient scientific data. The review describes current information and achievements in the field of application, efficacy and safety of mycophenolate mofetil.
霉酚酸酯是一种抗代谢物,对T淋巴细胞和B淋巴细胞的增殖具有强大的抑制作用,自20世纪90年代初以来,该药物被用于预防器官移植后的急性移植排斥反应。也广泛用于治疗各种风湿性疾病伴肺损伤。间质性肺病是一种异质性的进行性纤维化肺病,通常继发于风湿性疾病,是常见的死亡原因。霉酚酸酯是环磷酰胺的主要替代品,作为治疗与风湿性疾病相关的间质性肺疾病的一线药物,或作为环磷酰胺治疗后可能的维持治疗,副作用发生率较低。然而,在风湿病相关的间质性肺疾病中使用霉酚酸酯尚无足够的科学数据。综述了霉酚酸酯在应用、疗效和安全性方面的最新进展。
{"title":"The use of mycophenolate mofetil in interstitial lung diseases associated with rheumatic diseases","authors":"E. Ionova","doi":"10.12737/2409-3750-2023-8-4-13-19","DOIUrl":"https://doi.org/10.12737/2409-3750-2023-8-4-13-19","url":null,"abstract":"Mycophenolate mofetil is an antimetabolite with a powerful inhibitory effect on the proliferation of T and B lymphocytes, the drug has been used since the early 1990s to prevent acute graft rejection after organ transplantation. It is also widely used for the treatment of various rheumatic diseases with lung damage. Interstitial lung disease is a heterogeneous group of progressive fibrotic lung diseases, which is often secondary to rheumatic disease and is a common cause of death. Mycophenolate mofetil is the main alternative to cyclophosphamide as a first-line drug for the treatment of interstitial lung diseases associated with rheumatic diseases, or as a possible maintenance therapy after treatment with cyclophosphamide with a lower frequency of side effects. However, the use of mycophenolate mofetil in interstitial lung diseases associated with rheumatic diseases has insufficient scientific data. The review describes current information and achievements in the field of application, efficacy and safety of mycophenolate mofetil.","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"20 5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82905768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary amyloidosis as a complication of rheumatoid arthritis in a patient with low adherence to treatment 继发性淀粉样变作为类风湿关节炎患者的并发症,治疗依从性低
Pub Date : 2023-02-01 DOI: 10.12737/2409-3750-2023-8-4-35-40
D. Nikulina
A case of secondary amyloidosis in rheumatoid arthritis in a 28-year-old girl who did not receive sufficient basic therapy due to low adherence to treatment is presented. During the course of the disease, proteinuria developed, widespread edema, digestive disorders. The development of symptoms over time, the process of diagnosis, the selection of therapy, rehabilitation are demonstrated.
一个28岁的女孩继发性淀粉样变在类风湿关节炎谁没有得到足够的基础治疗,由于治疗依从性低提出。病程中出现蛋白尿、广泛性水肿、消化系统紊乱。随着时间的推移,症状的发展,诊断的过程,治疗的选择,康复证明。
{"title":"Secondary amyloidosis as a complication of rheumatoid arthritis in a patient with low adherence to treatment","authors":"D. Nikulina","doi":"10.12737/2409-3750-2023-8-4-35-40","DOIUrl":"https://doi.org/10.12737/2409-3750-2023-8-4-35-40","url":null,"abstract":"A case of secondary amyloidosis in rheumatoid arthritis in a 28-year-old girl who did not receive sufficient basic therapy due to low adherence to treatment is presented. During the course of the disease, proteinuria developed, widespread edema, digestive disorders. The development of symptoms over time, the process of diagnosis, the selection of therapy, rehabilitation are demonstrated.","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73415797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Problems of diagnosis and treatment of systemic lupus erythematosus in a young girl 年轻女孩系统性红斑狼疮的诊断和治疗问题
Pub Date : 2023-02-01 DOI: 10.12737/2409-3750-2023-8-4-30-32
L. Zhuravleva
The article describes a clinical case of acute systemic lupus erythematosus in a girl of reproductive age with secondary antiphospholipid syndrome. The diagnosis was made 1 year after the first clinical symptoms. The treatment was carried out with hormonal drugs, immunosuppressants and genetically engineered biological drugs.
本文描述了一个育龄女孩继发抗磷脂综合征的急性系统性红斑狼疮的临床病例。诊断是在首次出现临床症状1年后做出的。治疗采用激素药物、免疫抑制剂和基因工程生物药物。
{"title":"Problems of diagnosis and treatment of systemic lupus erythematosus in a young girl","authors":"L. Zhuravleva","doi":"10.12737/2409-3750-2023-8-4-30-32","DOIUrl":"https://doi.org/10.12737/2409-3750-2023-8-4-30-32","url":null,"abstract":"The article describes a clinical case of acute systemic lupus erythematosus in a girl of reproductive age with secondary antiphospholipid syndrome. The diagnosis was made 1 year after the first clinical symptoms. The treatment was carried out with hormonal drugs, immunosuppressants and genetically engineered biological drugs.","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"130 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79606119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variants of the course of ankylosing spondylitis on the example of a clinical case of twin brothers 变异性强直性脊柱炎病程以一对双胞胎兄弟的临床病例为例
Pub Date : 2023-02-01 DOI: 10.12737/2409-3750-2023-8-4-25-29
O. Dvornikova
The case of ankylosing spondylitis in twin brothers is considered. The influence of various factors on the trigger mechanism of the disease is analyzed. Both twin brothers have a genetic predisposition to the disease, but only one of them has provoking agents, in the form of injury and inflammation.
强直性脊柱炎在双胞胎兄弟的情况下考虑。分析了各种因素对该病发病机制的影响。这对双胞胎兄弟都有患这种疾病的遗传倾向,但其中只有一个有刺激物,以损伤和炎症的形式出现。
{"title":"Variants of the course of ankylosing spondylitis on the example of a clinical case of twin brothers","authors":"O. Dvornikova","doi":"10.12737/2409-3750-2023-8-4-25-29","DOIUrl":"https://doi.org/10.12737/2409-3750-2023-8-4-25-29","url":null,"abstract":"The case of ankylosing spondylitis in twin brothers is considered. The influence of various factors on the trigger mechanism of the disease is analyzed. Both twin brothers have a genetic predisposition to the disease, but only one of them has provoking agents, in the form of injury and inflammation.","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76074930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic bone damage in prostate cancer as a cause of chronic musculoskeletal pain 前列腺癌的转移性骨损伤是慢性肌肉骨骼疼痛的一个原因
Pub Date : 2023-02-01 DOI: 10.12737/2409-3750-2023-8-4-20-24
O. Blashkevich
A clinical case of detection of prostate cancer with multiple bone metastases is presented. It has been clearly demonstrated that oncopathology in the early stages may go unnoticed due to the absence of specific symptoms, as well as the ability to mimic other nosologies in clinical manifestations during its progression. The importance of oncological alertness on the part of the doctor is shown, the need for medical examination is once again emphasized.
本文报告一例前列腺癌合并多发性骨转移的临床病例。已经清楚地证明,早期阶段的肿瘤病理可能被忽视,因为没有特定的症状,以及在其进展过程中临床表现模仿其他疾病的能力。这表明了医生警惕肿瘤的重要性,再次强调了医学检查的必要性。
{"title":"Metastatic bone damage in prostate cancer as a cause of chronic musculoskeletal pain","authors":"O. Blashkevich","doi":"10.12737/2409-3750-2023-8-4-20-24","DOIUrl":"https://doi.org/10.12737/2409-3750-2023-8-4-20-24","url":null,"abstract":"A clinical case of detection of prostate cancer with multiple bone metastases is presented. It has been clearly demonstrated that oncopathology in the early stages may go unnoticed due to the absence of specific symptoms, as well as the ability to mimic other nosologies in clinical manifestations during its progression. The importance of oncological alertness on the part of the doctor is shown, the need for medical examination is once again emphasized.","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79876008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and Functional Analysis of Serum Specific miRNAs in Recurrent Aphthous Stomatitis Patients with Excess-heat or Yin-deficiency 温热阴虚复发性口腔炎患者血清特异性mirna的鉴定及功能分析
Pub Date : 2023-01-05 DOI: 10.1016/j.ccmp.2023.100079
Jie Bao , Zhengyang Zhu , Xizhao Zhang , Lin Huang , Li Xu , Xiaobing Dou , Yongsheng Fan

Background

The treatment of Traditional Chinese Medicine (TCM) in recurrent aphthous stomatitis (RAS) based on syndrome differentiation has won the international acceptance, but the molecular mechanism of excess-heat syndrome and yin-deficiency syndrome of RAS remains unclear.

Objective

To clarify specific microRNAs (miRNAs) and their functions in RAS patients with excess-heat or yin-deficiency.

Methods

Serum samples were collected from patients meeting the RAS diagnostic criteria of excess-heat or yin-deficiency syndrome and healthy individuals. Core miRNAs were then identified under miRNA microarray analyses. Target prediction and bioinformatic analyses were carried out and gene-pathway-networks were visualized to better understand the relationship between different genes and pathways.

Results

(1) 90 individuals meeting the inclusion criteria were collected in this study. Among them, 9 miRNAs were screened out in excess-heat syndrome group (EH group), with 1 upregulated and 8 downregulated. And four miRNAs (hsa-miR-20b-5p, hsa-miR-122–5p, hsa-miR-483–5p and hsa-miR-3197) were validated by real-time PCR method. 14 miRNAs were screened out in yin-deficiency syndrome group (YD group) (7 upregulated and 7 downregulated). And hsa-miR-17–5p, hsa-miR-106–5p and hsa-miR-20b-5p were validated. (2) A total of 4,776 target genes were identified in EH group which enriched in GO categories including nervous system development and calcium ion binding and pathway such as PI3K-Akt signaling pathway and Calcium signaling pathway. 10,172 target genes were identified in YD group which enriched GO categories included protein binding and positive regulation of transcription from RNA polymerase II promoter and pathway included MAPK signaling pathway and Ras signaling pathway.

Conclusion

Hsa-miR-20b-5p in patients with RAS could act as the novel target for the classification of the syndrome. It is upregulated in RAS patients with excess-heat syndrome while downregulated in patients with yin-deficiency syndrome. The PI3K-Akt and MAPK signaling pathways and their related target genes may provide new insights into the molecular mechanisms of RAS with excess-heat syndrome or yin-deficiency syndrome, respectively.

背景中医辨证论治复发性口口炎已获得国际认可,但其湿热证和阴虚证的分子机制尚不清楚。目的阐明湿热阴虚RAS患者的特异性微小RNA(miRNA)及其功能。方法收集符合湿热阴虚综合征RAS诊断标准的患者和健康人的血清样本。然后在miRNA微阵列分析下鉴定核心miRNA。进行了靶标预测和生物信息学分析,并对基因通路网络进行了可视化,以更好地理解不同基因和通路之间的关系。结果(1)本研究共收集到90名符合入选标准的个体。其中,过热综合征组(EH组)筛选出9个miRNA,其中1个上调,8个下调。通过实时PCR方法验证了四种miRNA(hsa-miR-20b-5p、hsa-miR-122-5p、hsa-miR-483-5p和hsa-miR-3197)。阴虚证组筛选出14个miRNA(上调7个,下调7个)。并对hsa-miR-17-5p、hsa-miR-106-5p和hsa-miR-20b-5p进行了验证。(2) EH组共鉴定出4776个靶基因,这些靶基因富含GO类别,包括神经系统发育和钙离子结合,以及PI3K-Akt信号通路和钙信号通路。在YD组中鉴定出10172个靶基因,其富集的GO类别包括蛋白质结合和RNA聚合酶II启动子转录的正调控,途径包括MAPK信号通路和Ras信号通路。结论RAS患者的Hsa-miR-20b-5p可作为该综合征分类的新靶点。它在RAS伴高热综合征的患者中上调,而在阴虚综合征患者中下调。PI3K-Akt和MAPK信号通路及其相关靶基因可能分别为RAS伴高热综合征或阴虚综合征的分子机制提供新的见解。
{"title":"Identification and Functional Analysis of Serum Specific miRNAs in Recurrent Aphthous Stomatitis Patients with Excess-heat or Yin-deficiency","authors":"Jie Bao ,&nbsp;Zhengyang Zhu ,&nbsp;Xizhao Zhang ,&nbsp;Lin Huang ,&nbsp;Li Xu ,&nbsp;Xiaobing Dou ,&nbsp;Yongsheng Fan","doi":"10.1016/j.ccmp.2023.100079","DOIUrl":"https://doi.org/10.1016/j.ccmp.2023.100079","url":null,"abstract":"<div><h3>Background</h3><p>The treatment of Traditional Chinese Medicine (TCM) in recurrent aphthous stomatitis (RAS) based on syndrome differentiation has won the international acceptance, but the molecular mechanism of excess-heat syndrome and yin-deficiency syndrome of RAS remains unclear.</p></div><div><h3>Objective</h3><p>To clarify specific microRNAs (miRNAs) and their functions in RAS patients with excess-heat or yin-deficiency<strong>.</strong></p></div><div><h3>Methods</h3><p>Serum samples were collected from patients meeting the RAS diagnostic criteria of excess-heat or yin-deficiency syndrome and healthy individuals. Core miRNAs were then identified under miRNA microarray analyses. Target prediction and bioinformatic analyses were carried out and gene-pathway-networks were visualized to better understand the relationship between different genes and pathways.</p></div><div><h3>Results</h3><p>(1) 90 individuals meeting the inclusion criteria were collected in this study. Among them, 9 miRNAs were screened out in excess-heat syndrome group (EH group), with 1 upregulated and 8 downregulated. And four miRNAs (hsa-miR-20b-5p, hsa-miR-122–5p, hsa-miR-483–5p and hsa-miR-3197) were validated by real-time PCR method. 14 miRNAs were screened out in yin-deficiency syndrome group (YD group) (7 upregulated and 7 downregulated). And hsa-miR-17–5p, hsa-miR-106–5p and hsa-miR-20b-5p were validated. (2) A total of 4,776 target genes were identified in EH group which enriched in GO categories including nervous system development and calcium ion binding and pathway such as PI3K-Akt signaling pathway and Calcium signaling pathway. 10,172 target genes were identified in YD group which enriched GO categories included protein binding and positive regulation of transcription from RNA polymerase II promoter and pathway included MAPK signaling pathway and Ras signaling pathway.</p></div><div><h3>Conclusion</h3><p>Hsa-miR-20b-5p in patients with RAS could act as the novel target for the classification of the syndrome. It is upregulated in RAS patients with excess-heat syndrome while downregulated in patients with yin-deficiency syndrome. The PI3K-Akt and MAPK signaling pathways and their related target genes may provide new insights into the molecular mechanisms of RAS with excess-heat syndrome or yin-deficiency syndrome, respectively.</p></div>","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"3 4","pages":"Article 100079"},"PeriodicalIF":0.0,"publicationDate":"2023-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49724796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulatory Effects of Mushrooms on the Inflammatory Signaling Pathways and Pro-inflammatory Mediators 蘑菇对炎症信号通路和促炎介质的调节作用
Pub Date : 2022-12-01 DOI: 10.1016/j.ccmp.2022.100037
Adekunle Rowaiye , Olobayotan Ifeyomi Wilfred , Olukemi Adejoke Onuh , Doofan Bur , Solomon Oni , Ezinne Janefrances Nwonu , Gordon Ibeanu , Angus Nnamdi Oli , Timipanipiri ThankGod Wood

Background

Mushrooms include a wide variety of bioactive compounds that have been linked to therapeutic and nutritional benefits, making them a potential source of new medications and functional foods.

Objective

The goal of this study is to offer a complete overview of the mushroom's modulatory effects on inflammatory signaling pathways, which leads to the inhibition of inflammation in various types of immune cells and animal models.

Methods

This study reviewed the inhibitory effects of mushrooms on the inflammation process through the modulation of the pro-inflammatory mediators and associated signaling pathways. A literature search in PubMed and Google Scholar was conducted for the relevant original research and review articles on the anti-inflammatory effects of mushrooms. Related articles published in English were selected, studied and discussed.

Results

As revealed by the selected articles, bioactive molecules which include peptides, polysaccharides, terpenes, sterols, fatty acids, and phenols have been extracted from the powder, concentrate, and different solvent extracts of edible mushrooms. These bioactive molecules have shown significant efficacy in inhibiting the major pro-inflammatory biomarkers and associated pathways in in vivo and in vitro settings.

Conclusion

This review demonstrated that mushrooms significantly inhibit the production of pro-inflammatory mediators and can be developed for clinical use as anti-inflammatory agents. Further research is required to establish the comparative efficacy between mushrooms and NSAID especially in the in vivo inhibitory activity against the production of cyclooxygenase and pro-inflammatory cytokines.

蘑菇含有各种各样的生物活性化合物,这些化合物与治疗和营养益处有关,使它们成为新药和功能食品的潜在来源。目的本研究的目的是全面概述蘑菇对炎症信号通路的调节作用,从而导致各种免疫细胞和动物模型的炎症抑制。方法本研究通过对促炎介质及相关信号通路的调节,综述了蘑菇对炎症过程的抑制作用。在PubMed和谷歌Scholar上检索蘑菇抗炎作用的相关原创研究和综述文章。选取相关的英文文章,进行研究和讨论。结果从食用菌粉末、浓缩液和不同溶剂提取物中均可提取到多肽、多糖、萜烯、甾醇、脂肪酸、酚类等生物活性分子。这些生物活性分子在体内和体外环境中显示出显著的抑制主要促炎生物标志物和相关途径的功效。结论蘑菇可明显抑制促炎介质的产生,可作为抗炎药物开发应用于临床。需要进一步的研究来确定蘑菇和非甾体抗炎药之间的比较功效,特别是在体内抑制环加氧酶和促炎细胞因子的产生。
{"title":"Modulatory Effects of Mushrooms on the Inflammatory Signaling Pathways and Pro-inflammatory Mediators","authors":"Adekunle Rowaiye ,&nbsp;Olobayotan Ifeyomi Wilfred ,&nbsp;Olukemi Adejoke Onuh ,&nbsp;Doofan Bur ,&nbsp;Solomon Oni ,&nbsp;Ezinne Janefrances Nwonu ,&nbsp;Gordon Ibeanu ,&nbsp;Angus Nnamdi Oli ,&nbsp;Timipanipiri ThankGod Wood","doi":"10.1016/j.ccmp.2022.100037","DOIUrl":"10.1016/j.ccmp.2022.100037","url":null,"abstract":"<div><h3>Background</h3><p>Mushrooms include a wide variety of bioactive compounds that have been linked to therapeutic and nutritional benefits, making them a potential source of new medications and functional foods.</p></div><div><h3>Objective</h3><p>The goal of this study is to offer a complete overview of the mushroom's modulatory effects on inflammatory signaling pathways, which leads to the inhibition of inflammation in various types of immune cells and animal models.</p></div><div><h3>Methods</h3><p>This study reviewed the inhibitory effects of mushrooms on the inflammation process through the modulation of the pro-inflammatory mediators and associated signaling pathways. A literature search in PubMed and Google Scholar was conducted for the relevant original research and review articles on the anti-inflammatory effects of mushrooms. Related articles published in English were selected, studied and discussed.</p></div><div><h3>Results</h3><p>As revealed by the selected articles, bioactive molecules which include peptides, polysaccharides, terpenes, sterols, fatty acids, and phenols have been extracted from the powder, concentrate, and different solvent extracts of edible mushrooms. These bioactive molecules have shown significant efficacy in inhibiting the major pro-inflammatory biomarkers and associated pathways in <em>in vivo</em> and <em>in vitro</em> settings.</p></div><div><h3>Conclusion</h3><p>This review demonstrated that mushrooms significantly inhibit the production of pro-inflammatory mediators and can be developed for clinical use as anti-inflammatory agents. Further research is required to establish the comparative efficacy between mushrooms and NSAID especially in the <em>in vivo</em> inhibitory activity against the production of cyclooxygenase and pro-inflammatory cytokines.</p></div>","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"2 4","pages":"Article 100037"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772371222000183/pdfft?md5=af04ebddc868ba88db7b910a10de37f3&pid=1-s2.0-S2772371222000183-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43890939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Fifty-year of Global Research in Calendula Officinalis L. (1971−2021): A Bibliometric Study 金盏菊全球研究50年(1971 - 2021):文献计量学研究
Pub Date : 2022-12-01 DOI: 10.1016/j.ccmp.2022.100059
Siddig Ibrahim Abdelwahab , Manal Mohamed Elhassan Taha , Sarah Mohamed Elhassan Taha , Abdulrahman Ahmed Alsayegh

Background

Calendula officinalis L. (Compositae) is a Mediterranean annual plant widely used for its versatile biological activities.

Objective

A bibliometric study of research data conducted from 1971 to 2021 was conducted.

Methods

Bibliographic data was retrieved from the Scopus database and analyzed using VOSviewer and MS Excel. Polynomial regression was used to assess the annual production of research documents related to C. officinalis.

Results

A total of 1,252 journal articles and conference papers were published by 4,452 authors, originated from 98 countries and disseminated in 706 sources. Iran (n = 131), Brazil (n = 119), India (n = 113), Poland (n = 112), and Italy (n = 72) are the top-publishing countries. Journal of Ethnopharmacology is the top-cited journal, while Italy is the top-cited country. Steady growth was observed in the last fifty years, from 1971 to 2021. The anti-inflammatory, wound-healing, and anti-microbial properties are among the most prolific studies that have been conducted on this plant. Extensive research has been carried out on antioxidant compounds, terpenes, and volatile oils. Skin care and wound healing are the most common clinical applications. Co-citation analysis, keywords co-occurrence, and bibliographic coupling revealed diverse knowledge structures and intellectual dynamics.

Conclusion

This comprehensive bibliometric study indicates that Calendula officinalis received significant research. The structured information may help understand research trends and locate this plant's research hot spots and gaps.

金盏菊(calendula officinalis L.)是一种地中海一年生植物,因其多种生物活性而被广泛应用。目的对1971 ~ 2021年的研究资料进行文献计量学分析。方法从Scopus数据库中检索文献资料,使用VOSviewer和MS Excel进行分析。采用多项式回归的方法对马蹄草相关文献的年产出量进行评估。结果共发表期刊论文和会议论文1252篇,作者4452人,来源98个国家,传播源706个。伊朗(n = 131)、巴西(n = 119)、印度(n = 113)、波兰(n = 112)和意大利(n = 72)是发表论文最多的国家。《民族药理学杂志》(Journal of Ethnopharmacology)是被引用最多的期刊,而意大利是被引用最多的国家。从1971年到2021年的过去50年里,观察到稳定的增长。抗炎、伤口愈合和抗微生物特性是对这种植物进行的最多产的研究之一。对抗氧化化合物、萜烯和挥发油进行了广泛的研究。皮肤护理和伤口愈合是最常见的临床应用。共被引分析、关键词共现和书目耦合揭示了不同的知识结构和智力动态。结论综合文献计量学研究表明,金盏菊具有重要的研究价值。结构化的信息有助于了解研究趋势,定位该植物的研究热点和空白。
{"title":"Fifty-year of Global Research in Calendula Officinalis L. (1971−2021): A Bibliometric Study","authors":"Siddig Ibrahim Abdelwahab ,&nbsp;Manal Mohamed Elhassan Taha ,&nbsp;Sarah Mohamed Elhassan Taha ,&nbsp;Abdulrahman Ahmed Alsayegh","doi":"10.1016/j.ccmp.2022.100059","DOIUrl":"10.1016/j.ccmp.2022.100059","url":null,"abstract":"<div><h3>Background</h3><p><em>Calendula officinalis</em> L. (Compositae) is a Mediterranean annual plant widely used for its versatile biological activities.</p></div><div><h3>Objective</h3><p>A bibliometric study of research data conducted from 1971 to 2021 was conducted.</p></div><div><h3>Methods</h3><p>Bibliographic data was retrieved from the Scopus database and analyzed using <em>VOSviewer</em> and MS Excel. Polynomial regression was used to assess the annual production of research documents related to <em>C. officinalis</em>.</p></div><div><h3>Results</h3><p>A total of 1,252 journal articles and conference papers were published by 4,452 authors, originated from 98 countries and disseminated in 706 sources. Iran (<em>n</em> = 131), Brazil (<em>n</em> = 119), India (<em>n</em> = 113), Poland (<em>n</em> = 112), and Italy (<em>n</em> = 72) are the top-publishing countries. <em>Journal of Ethnopharmacology</em> is the top-cited journal, while Italy is the top-cited country. Steady growth was observed in the last fifty years, from 1971 to 2021. The anti-inflammatory, wound-healing, and anti-microbial properties are among the most prolific studies that have been conducted on this plant. Extensive research has been carried out on antioxidant compounds, terpenes, and volatile oils. Skin care and wound healing are the most common clinical applications. Co-citation analysis, keywords co-occurrence, and bibliographic coupling revealed diverse knowledge structures and intellectual dynamics.</p></div><div><h3>Conclusion</h3><p>This comprehensive bibliometric study indicates that <em>Calendula officinalis</em> received significant research. The structured information may help understand research trends and locate this plant's research hot spots and gaps.</p></div>","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"2 4","pages":"Article 100059"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772371222000390/pdfft?md5=8a705cb3b01028a8eb06bd50741638d6&pid=1-s2.0-S2772371222000390-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43078681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
期刊
Clinical complementary medicine and pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1